Dr. Zhang serves as OmniSeq’s Laboratory Director. Dr. Zhang, a board-certified molecular diagnostic and molecular genetic pathologist, has more than 30 years of proven experience in the molecular diagnostic oncology space, both as a practitioner and in the academic research space.
As laboratory director at OmniSeq, he will direct OmniSeq’s clinical laboratory operations in its performance of OmniSeq’s genomic and immune profiling tests. Dr. Zhang will also participate in biomarker discovery and clinical trial projects as well as OmniSeq’s new clinical test development initiatives.
Dr. Zhang joins OmniSeq from SUNY Upstate Medical University in Syracuse, New York — the only academic medical center in Central New York. During his distinguished 15-year career there, he served as both assistant director of Upstate University Hospital’s molecular diagnostic laboratory, director of its anatomical pathology laboratory, a professor of pathology and a molecular and surgical pathologist. Dr. Zhang’s research has been published in several leading journals, including Science, Cancer Research, Diagnostic Molecular Pathology and Journal of Clinical Oncology. He holds memberships in the College of American Pathologists, US and Canadian Academy of Pathology, and the Association for Molecular Pathology.